Who owns APELLIS PHARMACEUTICALS INC?
- CUSIP Number: 03753uab2
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Apellis Pharmaceuticals stock
Who bought or sold APELLIS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
DeepCurrents Investment Group | 41M | $66M | 3% | Dec 2023 |
|
Lazard Asset Management | 16M | $26M | 30% | Dec 2023 |
|
Wolverine Asset Management | 12M | $19M | 0% | Dec 2023 |
|
D. E. Shaw & Co | 5.0M | $8.2M | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 2.5M | $3.7M | 109% | Dec 2023 |
|
Wellington Management Company | 1.3M | $2.1M | 0% | Dec 2023 |
|
Palisade Capital Management | 1.0M | $1.7M | 0% | Dec 2023 |
|
Citigroup | 504k | $821k | 0% | Dec 2023 |
|
Kornitzer Capital Management | 300k | $489k | 0% | Dec 2023 |
|